Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: A comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol

Journal of Crohn's and Colitis

Volumn 7, Issue 8, 2013, Pages 622-630

  Gologan, Serban ^a   Iacob, Razvan ^a,b   Iancu, Daniela ^c   Iacob, Speranta ^b   Cotruta, Bogdan ^b   Vadan, Roxana ^b   Catuneanu, Ana Maria ^b   Constantinescu, Ileana ^b   Barbarii, Ligia ^c   Gheorghe, Cristian ^a,b   Diculescu, Mircea ^a,b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b FUNDENI CLINICAL INSTITUTE   (Romania)

^c NATIONAL INSTITUTE OF LEGAL MEDICINE MINA MINOVICI   (Romania)

Author keywords

Crohn's disease; Cytokines; Gene expression; Inflammatory bowel disease; RT MLPA; Ulcerative colitis

Indexed keywords

GLUTATHIONE TRANSFERASE P1; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 2; RNA DIRECTED DNA POLYMERASE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; COLON BIOPSY; COLONOSCOPY; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS;

CROHN'S DISEASE; CYTOKINES; GENE EXPRESSION; INFLAMMATORY BOWEL DISEASE; RT-MLPA; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; CHEMOKINES; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PHENOTYPE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84880040131     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.08.015     Document Type: Article

References (27)

1. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
2. Kucharzik T., Maaser C., Lugering A., Kagnoff M., Mayer L., Targan S., et al. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis 2006, 12:1068-1083.
3. Matricon J., Barnich N., Ardid D. Immunopathogenesis of inflammatory bowel disease. Self/Nonself 2010, 1:299-309.
4. Koizumi M., King N., Lobb R., Benjamin C., Podolsky D.K. Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 1992, 103:840-847.
5. Atreya R., Neurath M.F. Chemokines in inflammatory bowel diseases. Dig Dis 2010, 28:386-394.
6. Reimund J.M., Wittersheim C., Dumont S., Muller C.D., Kenney J.S., Baumann R., et al. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996, 39:684-689.
7. Satsangi J., Silverberg M.S., Vermeire S., Colombel J.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006, 55:749-753.
8. Nielsen O.H., Kirman I., Rüdiger N., Hendel J., Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol 2003, 38:180-185.
9. Matsuda R., Koide T., Tokoro C., Yamamoto T., Godai T., Morohashi T., et al. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naive ulcerative colitis during active and quiescent disease. Inflamm Bowel Dis 2009, 15:328-334.
10. Uguccioni M., Gionchetti P., Robbiani D.F., Rizzello F., Peruzzo S., Campieri M., et al. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 1999, 155:331-336.
11. Fukushima K., West G., Fiocchi C. Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA. Comparative study of RT-PCR in biopsies and isolated cells from normal and inflamed intestine. Dig Dis Sci 1995, 40:1498-1505.
12. Autschbach F., Braunstein J., Helmke B., Zuna I., Schürmann G., Niemir Z.I., et al. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol 1998, 153:121-130.
13. Inoue S., Matsumoto T., Iida M., Mizuno M., Kuroki F., Hoshika K., et al. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity. Am J Gastroenterol 1999, 94:2441-2446.
14. Desreumaux P., Brandt E., Gambiez L., Emilie D., Geboes K., Klein O., et al. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 1997, 113:118-126.
15. León A.J., Gómez E., Garrote J.A., Bernardo D., Barrera A., Marcos J.L., et al. High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD. Mediators Inflamm 2009, 580450.
16. Scaldaferri F., Correale C., Gasbarrini A., Danese S. Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?. World J Gastroenterol 2010, 16:2616-2625.
17. Janczewska I., Kapraali M., Saboonchi F., Nekzada Q., Wessulv A., Khoshkar J., et al. Clinical application of the multigene analysis test in discriminating between ulcerative colitis and Crohn's disease: a retrospective study. Scand J Gastroenterol 2012, 47:162-169.
18. Gielen A., Sundell T., von Stein P. DiBiCol® - development of a multigene diagnostic test for the differentiation of inflammatory bowel disease subtypes. Eur Gastroenterol Hepatol Rev 2012, 8:40-43.
19. Schmidt C., Giese T., Ludwig B., Mueller-Molaian I., Marth T., Zeuzem S., et al. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 2005, 11:16-23.
20. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
21. Peluso I., Pallone F., Monteleone G. Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol 2006, 12:5606-5610.
22. Banks C., Bateman A., Payne R., Johnson P., Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003, 199:28-35.
23. Katsuta T., Lim C., Shimoda K., Shibuta K., Mitra P., Banner B.F., et al. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease. Am J Gastroenterol 2000, 95:3157-3164.
24. Keshavarzian A., Fusunyan R.D., Jacyno M., Winship D., Mac-Dermott R.P., Sanderson I.R. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol 1999, 94:704-712.
25. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991, 147:3815-3822.
26. Gomes-Santos A.C., Moreira T.G., Castro-Junior A.B., Horta B.C., Lemos L., Cruz D.N., et al. New insights into the immunological changes in IL-10-deficient mice during the course of spontaneous inflammation in the gut mucosa. Clin Dev Immunol 2012, 560817.
27. Paul G., Khare V., Gasche C. Inflamed gut mucosa: downstream of interleukin-10. Eur J Clin Invest 2012, 42:95-109.